Research aims to make sure that patients only receive drugs that will work specifically for their own disease Wednesday, 10 October 2018: Researchers at RCSI/CSM, along with international collaborators within …
TY-programme-Application-form (1)
Scientists discover predictive biomarker for key colorectal cancer drug Friday, 01 June 2018: The ANGIOPREDICT research consortium have discovered a potential biomarker that can predict which patients will receive most benefit …
Monday 30th April 34 students and 2 professors from Radboud University Nijmegen (the Netherlands) visited RCSI and the CSM labs. They were welcomed by Prof. Prehn and Dr Helena Bonner …
Our miRNAmeConverter package (https://bit.ly/2fFe5BA) now supports miRBase 22! (doi:10.1093/bioinformatics/btw660)
The PurinesDX consortium (coordinated by Dr Tobias Engel, RCSI) will be hosting its first meeting on April 24th 2018 at the Cheyne Lecture Theatre – see programme attached! Registration (free) …
Irish scientists raise new hope in fight against aggressive breast cancer Doctors may soon be able to spare some cancer patients the harsh effects of chemotherapy. Researchers from RCSI and …
Applications are invited from candidates of excellence wishing to pursue a PhD degree in the field of cancer precision medicine. Students will receive training within a pan-European academic/privatesector research training …
Title of project: Carbon-Model: Carbon metabolism systems analysis for the identification of disease and patient-specific metabolic and energetic defects in neurodegenerative diseases awarded to Prof. Jochen Prehn and Co-applicants: Dr. …
Prof Annette Byrne, GLIOTRAIN Coordinator is taking part in this joint event on 9th March organised by Brain Tumour Ireland and RCSI, as part of Brain Awareness Week 2018. The …